Palidye Holdings (Caymans)’s Medpace MEDP Stock Holding History

Palidye Holdings (Caymans)’s Portfolio MEDP Stock Details MEDP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,300	Closed	-$1.29M	–	15
2025 Q4	$1.29M	Buy	+2,300	New	+$1.31M	0.26%	12

Other funds holding MEDP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Palidye Holdings (Caymans)'s MEDP Position: Q1 2026 in Review

Palidye Holdings (Caymans) sold out of Medpace (MEDP) in Q1 2026, closing a stake of 2,300 shares — an estimated $1.29M sold.

Palidye Holdings (Caymans) first reported a position in MEDP in Q4 2025 and held it in 1 quarter. The position peaked at $1.29M in Q4 2025. 733 funds tracked by Wall St. Rank hold MEDP as of Q1 2026.

Palidye Holdings (Caymans) reported no remaining Medpace position as of Q1 2026 after selling out during the quarter.
Palidye Holdings (Caymans) sold 2,300 Medpace shares in Q1 2026, an estimated $1.29M.
Palidye Holdings (Caymans) first reported a position in Medpace in Q4 2025 and held it in 1 quarter.
Palidye Holdings (Caymans)'s Medpace position peaked at $1.29M in Q4 2025.
733 funds tracked by Wall St. Rank held Medpace as of Q1 2026.

Based on Palidye Holdings (Caymans)'s 13F filing for Q1 2026, filed 15 May 2026.